These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23610785)

  • 21. [In vivo sensitivity of Plasmodium falciparum to amino-4-quinolines and sulfadoxine pyrimethamine in Agou (Ivory Coast)].
    Yavo W; Menan EI; Adjetey TA; Barro-Kiki PC; Nigué L; Konan YJ; Nebavi NG; Koné M
    Pathol Biol (Paris); 2002 Apr; 50(3):184-8. PubMed ID: 11980332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haplotypes associated with resistance to sulfadoxine-pyrimethamine in Plasmodium falciparum in two malaria endemic locations in Colombia.
    Hernández DC; Guerra AP; Cucunubá ZM; Nicholls RS; Barrera SM
    Infect Genet Evol; 2013 Aug; 18():183-90. PubMed ID: 23714094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo sensitivity of Plasmodium falciparum to chloroquine, amodiaquine and sulfadoxine-pyrimethamine in western Uganda.
    Kamugisha J; Kipp W; Burnham G
    Trop Geogr Med; 1994; 46(6):364-5. PubMed ID: 7892705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of resistance by Plasmodium falciparum to sulfadoxine/pyrimethamine in Amhara Region, Northwestern Ethiopia.
    Kassa M; Sileshi M; Mohammed H; Taye G; Asfaw M
    Ethiop Med J; 2005 Jul; 43(3):181-7. PubMed ID: 16370550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The differing impact of chloroquine and pyrimethamine/sulfadoxine upon the infectivity of malaria species to the mosquito vector.
    Hogh B; Gamage-Mendis A; Butcher GA; Thompson R; Begtrup K; Mendis C; Enosse SM; Dgedge M; Barreto J; Eling W; Sinden RE
    Am J Trop Med Hyg; 1998 Feb; 58(2):176-82. PubMed ID: 9502601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine/pyrimethamine in pregnant women in Yaoundé, Cameroon: emergence of highly resistant pfdhfr/pfdhps alleles.
    Chauvin P; Menard S; Iriart X; Nsango SE; Tchioffo MT; Abate L; Awono-Ambéné PH; Morlais I; Berry A
    J Antimicrob Chemother; 2015 Sep; 70(9):2566-71. PubMed ID: 26080363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic efficacy of quinine plus sulfadoxine-pyremethamine for the treatment of uncomplicated falciparum malaria in Bangladesh.
    Thriemer K; Haque R; Wagatsuma Y; Salam MA; Akther S; Attlmayr B; Fukuda M; Schaecher K; Miller RS; Noedl H
    Am J Trop Med Hyg; 2006 Oct; 75(4):645-9. PubMed ID: 17038687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasmodium falciparum: evaluation of a quantitative nucleic acid sequence-based amplification assay to predict the outcome of sulfadoxine-pyrimethamine treatment of uncomplicated malaria.
    Omar SA; Mens PF; Schoone GJ; Yusuf A; Mwangi J; Kaniaru S; Omer GA; Schallig HD
    Exp Parasitol; 2005 May; 110(1):73-9. PubMed ID: 15804381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Artemether treatment of sulfadoxine/pyrimethamine-resistant Plasmodium falciparum malaria in children.
    Sowunmi A; Oduola AM; Salako LA
    Trans R Soc Trop Med Hyg; 1995; 89(4):435-6. PubMed ID: 7570890
    [No Abstract]   [Full Text] [Related]  

  • 30. In vivo study of the response of Plasmodium falciparum to standard mefloquine/sulfadoxine/pyrimethamine (MSP) treatment among gem miners returning from Cambodia.
    Thimasarn K; Sirichaisinthop J; Vijaykadga S; Tansophalaks S; Yamokgul P; Laomiphol A; Palananth C; Thamewat U; Tháithong S; Rooney W
    Southeast Asian J Trop Med Public Health; 1995 Jun; 26(2):204-12. PubMed ID: 8629047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Point mutations in the dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum and resistance to sulfadoxine-pyrimethamine in Sri Lanka.
    Hapuarachchi HC; Dayanath MY; Bandara KB; Abeysundara S; Abeyewickreme W; de Silva NR; Hunt SY; Sibley CH
    Am J Trop Med Hyg; 2006 Feb; 74(2):198-204. PubMed ID: 16474070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo sulphadoxine-pyrimethamine sentitivity study Tigray Region, Southern Zone, Alamata Town, September--November 2001.
    Degefa T
    Ethiop Med J; 2004 Jan; 42(1):35-9. PubMed ID: 15884275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of genetic innate resistance and acquired immunity on drug treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania.
    Enevold A
    Parassitologia; 2006 Dec; 48(4):547-51. PubMed ID: 17688175
    [No Abstract]   [Full Text] [Related]  

  • 34. Chloroquine- and sulfadoxine-pyrimethamine-resistant Falciparum malaria in vivo - a pilot study in rural Zambia.
    Bijl HM; Kager J; Koetsier DW; van der Werf TS
    Trop Med Int Health; 2000 Oct; 5(10):692-5. PubMed ID: 11044263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mefloquine--its 20 years in the Thai Malaria Control Program.
    Wongsrichanalai C; Prajakwong S; Meshnick SR; Shanks GD; Thimasarn K
    Southeast Asian J Trop Med Public Health; 2004 Jun; 35(2):300-8. PubMed ID: 15691128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High prevalence of pfdhfr-pfdhps triple mutations associated with anti-malarial drugs resistance in Plasmodium falciparum isolates seven years after the adoption of sulfadoxine-pyrimethamine in combination with artesunate as first-line treatment in Iran.
    Rouhani M; Zakeri S; Pirahmadi S; Raeisi A; Djadid ND
    Infect Genet Evol; 2015 Apr; 31():183-9. PubMed ID: 25653131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum must be delayed in Africa.
    Rieckmann K; Cheng Q
    Trends Parasitol; 2002 Jul; 18(7):293-4; author reply 294. PubMed ID: 12379946
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevention of increasing rates of treatment failure by combining sulfadoxine-pyrimethamine with artesunate or amodiaquine for the sequential treatment of malaria.
    Dorsey G; Vlahos J; Kamya MR; Staedke SG; Rosenthal PJ
    J Infect Dis; 2003 Oct; 188(8):1231-8. PubMed ID: 14551894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High prevalence of sulfadoxine/pyrimethamine-resistant alleles of Plasmodium falciparum isolates in pregnant women at the time of introduction of intermittent preventive treatment with sulfadoxine/pyrimethamine in Gabon.
    Bouyou-Akotet MK; Mawili-Mboumba DP; Tchantchou Tde D; Kombila M
    J Antimicrob Chemother; 2010 Mar; 65(3):438-41. PubMed ID: 20053688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selection of antimalarial drug resistance after intermittent preventive treatment of infants and children (IPTi/c) in Senegal.
    Ndiaye M; Tine R; Faye B; Ndiaye JL; Diouf I; Lo AC; Sylla K; Dieng Y; Hallett R; Alifrangis M; Gaye O
    C R Biol; 2013; 336(5-6):295-300. PubMed ID: 23916206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.